← Back to Search

ACP Specialist Program for Alzheimer's Disease (APPROACHES Trial)

N/A
Waitlist Available
Led By Susan Hickman, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

APPROACHES Trial Summary

This trial will test whether the ACP Specialist Program improves care for nursing home patients with Alzheimer's disease and related dementias.

Eligible Conditions
  • Alzheimer's Disease
  • Dementia

APPROACHES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Transfers
Secondary outcome measures
ACP preferences documentation
death in hospital
family satisfaction
+1 more

APPROACHES Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACP Specialist ProgramExperimental Treatment1 Intervention
The ACP Specialist will work with nursing home leaders to: i. Consolidate nursing home ACP procedures; ii. Train and educate staff; and iii. Facilitate ACP with patients who have Alzheimer's Disease/related dementias and their family caregivers.
Group II: ControlActive Control1 Intervention
There is no study interaction with control facilities. Facility will follow usual ACP procedures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ACP Specialist Program
2020
N/A
~22650

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
960,332 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
27,994,413 Total Patients Enrolled
Hebrew SeniorLifeOTHER
45 Previous Clinical Trials
247,906 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4384 spots leftby Apr 2025